Pricing Log in Create free account
Friday 6 November 2026 Export CBT’s income statement to Excel — free account

Cabot Corporation

CBT Basic Materials Specialty Chemicals

Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.

Revenue
+12.2%
EPS
+79.4%
Free cash flow
−51.7%
Total debt
+10.8%

Quarter to September 2026, against a year earlier

72.95 2.15 −2.86%
Market cap
$3.8B
P/E
17.4×
Fwd P/E
17.2×
Dividend yield
2.53%
F-score
6/9
Altman Z
3.53
Beneish M
−2.94
Dividend safety
85/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 19.65
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — 3 — — —
Insider Ownership 1.50%

Capital & Financial Ratios $m

Size
Market Cap 3,750.00
Revenue ttm 3,744.00
Net income ttm 247.00
Free cash flow ttm 214.00
Net debt Q 998.00
Valuation
P/E 17.42
Forward P/E 17.20
Price / sales 1.00
Forward P/S Powerpack
Price / FCF 17.56
Price / book 2.12
Financial health
Current ratio Q 2.16 (at or above 1.5: strong)
Debt / equity Q 0.71
Interest coverage Q 5.76
Growth
Revenue growth Q +12.24% (above 0%: growing)
Operating income growth Q −11.68% (below 0%: shrinking)
EPS, this year +3.85%
EPS, next year A +11.65%
Revenue, next year A −0.75% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A +7.38%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.3×, against a ten-year median of 1.3×; over the ten years it ranged from 0.8× in 2020 to 1.8× in 2017.
P/E against its own 10 years 62.63%
10-year low 10-year high
P/S against its own 10 years 41.69%
10-year low 10-year high
P/B against its own 10 years 12.76%
10-year low 10-year high
EV/Sales against its own 10 years 38.14%
10-year low 10-year high
EV/FCF against its own 10 years 58.38%
10-year low 10-year high

Dividends raised every year since 2017

Yield
2.53%
Annual rate
1.85
Payout ratio
44.3%
Growth, 2017–25
+4.57%/yr
  1. 1.25 ’17
  2. 1.31 ’18 +5
  3. 1.38 ’19 +6
  4. 1.40 ’20 +1
  5. 1.42 ’21 +1
  6. 1.48 ’22 +4
  7. 1.57 ’23 +6
  8. 1.69 ’24 +8
  9. 1.78 ’25 +5
  10. 1.86 ’26e +5
paid forecast change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 238 223 258 254
Receivables 695 733 671 801
Inventory 585 552 504 584
Other — — — —
1,626 1,605 1,539 1,746
2023 2024 2025 Q'26
Payables 600 676 648 716
ST’ Debt 182 53 274 72
Other — — — —
822 772 957 809

Compound Annual Growth %

10y 5y 3y
Sales 2.61% 7.27% (4.93%)
Cash Flow 2.91% 12.02% 88.05%
Earnings 0.00% 0.00% 16.56%
Book Value 2.45% 15.94% 18.22%

Earnings Trends EPS, adjusted, against the consensus

Q4 FY26 Estimate 1.55 Actual 1.61

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q1 FY26 1.40 1.53 Beat by 0.13
Q2 FY26 1.47 1.61 Beat by 0.14
Q3 FY26 1.66 1.67 Beat by 0.01
Q4 FY26 1.55 1.61 Beat by 0.06
Q1 FY27 1.58 — Reports 2 February 2027

EPS $

Dec Mar Jun Sep Year
’26 1.37 1.27 0.12 1.41 —
’25 1.67 1.69 1.86 0.79 6.02
’24 0.88 1.49 1.94 2.43 6.72
’23 0.93 1.29 1.43 4.10 7.73
’22 (1.57) 1.84 1.69 1.64 3.62
’21 1.06 1.30 1.48 0.50 4.34
’20 0.70 (0.01) (0.12) (4.81) (4.21)
Fiscal quarters ending in the months shown.

Revenue $m

Dec Mar Jun Sep Year
’26 849 904 982 1,009 —
’25 955 936 923 899 3,713
’24 958 1,019 1,016 1,001 3,994
’23 965 1,033 968 965 3,931
’22 968 1,092 1,149 1,112 4,321
’21 746 842 917 904 3,409
’20 727 710 518 659 2,614
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Dec Mar Jun Sep Year
’26 126 77 75 143 —
’25 124 73 249 219 665
’24 105 176 207 204 692
’23 52 162 243 138 595
’22 (49) 10 34 105 100
’21 21 65 71 100 257
’20 105 24 149 99 377
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Dec Mar Jun Sep Year
’26 57 32 37 88 —
’25 47 1 161 182 391
’24 51 133 155 112 451
’23 24 111 163 60 358
’22 (79) (31) 2 15 (93)
’21 (8) 25 25 20 62
’20 37 (27) 106 61 177
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.7
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to September

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 2,411 2,717 3,242 3,337 2,614 3,409 4,321 3,931 3,994 3,713 3,744 +4.9% 3,685 3,802 3,939 +2.0%
Gross margin, % 23.85 24.18 23.81 20.53 19.13 23.44 20.48 21.34 24.04 25.32 21.61 +1.5 pt
EBT 191 299 117 255 (33) 406 335 451 529 565 406 +12.8%
EBT margin, % 7.92 11.00 3.61 7.64 (1.26) 11.91 7.75 11.47 13.24 15.22 10.84 +7.3 pt
Net income 162 273 (74) 186 (221) 286 243 484 424 376 247 +9.8%
Per share, $
Per share, $ Revenue 38.64 43.61 52.54 56.85 46.18 60.12 76.48 70.07 72.49 69.14 72.70 +6.7%
Earnings 2.36 3.81 (1.85) 2.63 (4.21) 4.34 3.62 7.73 6.72 6.07 4.19 +11.1%
Cash flow 6.28 5.59 4.83 6.18 6.66 4.53 1.77 10.61 12.56 12.38 8.17 +7.8%
Capex (1.54) (2.36) (3.08) (3.82) (3.53) (3.44) (3.42) (4.22) (4.37) (5.10) (4.02) +14.2%
Free cash flow 4.74 3.23 1.75 2.37 3.13 1.09 (1.65) 6.38 8.19 7.28 4.16 +4.9%
Book value 21.99 26.08 20.73 19.32 14.38 19.22 18.27 25.08 28.86 31.75 34.39 +4.2%
Shares, m 62 62 62 59 57 57 57 56 55 54 52 (1.7%)
Valuation, ×
Valuation, × P/E 22.21 15.06 0.00 17.23 0.00 11.55 17.75 8.78 16.58 12.55 17.42 12.2
P/S 1.36 1.32 1.19 0.80 0.78 0.83 0.84 0.97 1.54 1.10 1.00 1.1
P/B 2.38 2.20 3.03 2.35 2.51 2.61 3.50 2.71 3.87 2.40 2.12 2.8
EV/Sales 1.65 1.55 1.45 1.07 1.15 1.13 1.12 1.24 1.77 1.33 1.27 1.3
EV/FCF 13.46 20.99 43.52 25.58 16.97 61.87 (52.12) 13.56 15.69 12.67 22.22 17.2
Cash, $m
Cash, $m Operating cash flow 392 348 298 363 377 257 100 595 692 665 421 +6.0%
Capex (96) (147) (190) (224) (200) (195) (193) (237) (241) (274) (207) +12.4%
Free cash flow 296 201 108 139 177 62 (93) 358 451 391 214 +3.1%
Balance, $m
Balance, $m Working capital 650 557 434 611 449 278 715 804 833 582 937 (1.2%)
Net debt 715 644 828 895 964 994 1,237 1,038 917 872 998 +2.2%
Shareholders’ equity 1,372 1,625 1,279 1,134 814 1,090 1,032 1,407 1,590 1,705 1,771 +2.4%
Returns, %
Returns, % ROA 4.78 7.78 (3.46) 5.03 (8.23) 8.21 6.12 12.48 10.35 8.77 5.41 +4.0 pt
ROIC 7.40 9.31 4.27 9.43 0.74 13.62 10.72 13.45 15.31 15.06 10.77 +7.7 pt
ROE 10.77 16.55 (7.85) 13.01 (24.44) 26.26 19.70 36.49 25.36 20.09 12.20 +9.3 pt
People
People Employees 4,300 4,500 4,600 4,500 4,500 4,500 4,200 4,300 4,200 4,100 — (0.5%)
Revenue/emp, $m 0.56 0.60 0.70 0.74 0.58 0.76 1.03 0.91 0.95 0.91 — +5.5%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Sep 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Cabot Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SXT Sensient Technologies Corporation $5.1B 30.0× 28.0× +10.61% (above 0%: growing) +31.03% (above 0%: growing) −90.87% (below 0%: shrinking) 36.19% 15.89% Compare
PRM Perimeter Solutions, SA $4.6B 102× 27.1× +23.59% (above 0%: growing) n/m −22.31% (below 0%: shrinking) 61.14% 106.82% Compare
AVNT Avient Corporation $4.2B 23.1× 17.6× +10.50% (above 0%: growing) +31.78% (above 0%: growing) +101.69% (above 0%: growing) 30.50% 9.27% Compare
CLMT Calumet, Inc. $3.8B — (loss-making) — (loss-making) +40.77% (above 0%: growing) n/m +450.65% (above 0%: growing) 1.27% (2.77%) Compare
CBT Cabot Corporation $3.8B 17.4× 17.2× +12.24% (above 0%: growing) +79.43% (above 0%: growing) −51.65% (below 0%: shrinking) 20.22% 11.99%
ASH Ashland Inc. $3.5B 67.1× 39.4× +4.40% (above 0%: growing) n/m +400.00% (above 0%: growing) 35.94% 5.82% Compare
HWKN Hawkins, Inc. $3.2B 36.6× 36.3× +11.90% (above 0%: growing) +23.06% (above 0%: growing) +1.32% (above 0%: growing) 24.41% 13.35% Compare
WDFC WD-40 Company $3.0B 37.0× 32.3× +8.14% (above 0%: growing) −31.85% (below 0%: shrinking) +63.49% (above 0%: growing) 52.78% 10.78% Compare
FUL H. B. Fuller Company $2.7B 13.8× 11.7× +5.17% (above 0%: growing) +18.19% (above 0%: growing) −58.41% (below 0%: shrinking) 33.22% 12.07% Compare
Median of peers $3.7B 36.6× 28.0× +10.56% +23.06% +32.41% 34.58% 11.43%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 27 January 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 9.31m 1.25m 235.00
2024 9.60m 26.15m 339.00
2023 7.79m 8.11m 206.00
2022 7.95m 17.16m 186.00
2021 8.24m 17.13m 143.00
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Read the proxy statement

Cabot Corporation (CBT) Latest News

4 Nov

Impact 3 · · Simply Wall St.

3 Nov

Impact 3 · · GuruFocus.com
Impact 3 · · MarketBeat
Impact 3 · · The Motley Fool transcript
Impact 3 · · Moby

2 Nov

Impact 3 · · Investing.com
Impact 3 · · GlobeNewswire

23 Oct

Impact 3 · · Simply Wall St.

21 Oct

Impact 3 · · Zacks

12 Oct

Impact 4 · · Zacks

8 Oct

Impact 3 · · Zacks

5 Oct

Impact 3 · · Zacks

23 Sep

Impact 4 · · Business Wire

18 Sep

Impact 4 ·

17 Sep

Impact 4 ·
Impact 4 ·
Impact 3 ·

9 Sep

Impact 3 ·

10 Aug

Impact 3 · · The Motley Fool transcript
Impact 3 ·

4 Aug

Impact 4 ·
Impact 3 · · MarketBeat
Impact 3 · · Moby transcript

31 Jul

Impact 3 ·

30 Jul

Impact 3 ·

24 Jul

Impact 3 ·

8 Jun

Impact 4 · · Simply Wall St.

3 Jun

Impact 3 · · CNW Group

8 May

Impact 4 · · Simply Wall St.

7 May

Impact 4 · · Zacks

CBT metrics, ten years each

stockrow.com/CBT · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com